Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
What is your approach to treatment when there is a multiple sclerosis reactivation while on natalizumab?
Related Questions
Which patients will have earlier diagnosis of multiple sclerosis via the new 2024 McDonald Criteria?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
When should patients be referred for advanced MRI testing to assess for CVS and PRL?
Is IVIG ever used to treat CNS neurosarcoidosis–related pain when the presentation is not consistent with peripheral neurosarcoid involvement?”
What biomarkers best predict the response to B-cell depleting therapies in MS?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
When would you obtain optic nerve testing in patients suspected to have multiple sclerosis without a clinical history of optic neuritis?
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?
How do you decide when to discontinue immunotherapy for primary angiitis of the central nervous system (PACNS)?
How do you interpret conflicting findings on CSF immunoglobulin tests for work up of multiple sclerosis and its mimics?
